New Irassen Injection (Jahageo Extract)

Adult administration

As Jahageo extract, administer 2 mL per dose, three times a week for two weeks (total of 6 doses) via subcutaneous injection.

This medicine is in ampoule injection form, and there is a risk of glass fragments mixing in when cutting the container, therefore it should be cut very carefully to minimize glass shard contamination, especially when used with children or the elderly. This product contains ingredients extracted from human placenta. While infection screenings are conducted during placenta collection and measures are taken during manufacturing to reduce the risk of infections, the risk of infection transmission cannot be completely eliminated. Therefore, this medicine should only be used minimally when absolutely necessary. This medicine contains benzyl alcohol, which can cause life-threatening respiratory issues in premature or low birth weight infants, so it should not be used in newborns or premature infants. Anyone who has had allergic reactions to this medicine or other medications, individuals with severe diseases other than heart, liver, or kidney issues, and those with psychogenic disorders should not use this medicine. Individuals with allergic tendencies should exercise special caution when using this medicine. If symptoms of shock, chills, nausea, fever, or skin rashes occur while using this medicine, it should be discontinued immediately and appropriate treatment should be sought. Pain or redness may develop at the injection site, and it may rarely cause breast pain or gynecomastia, in which case administration should also be stopped. It is important to thoroughly explain the need for treatment and the risk of infection before using this medicine and to ensure the patient's understanding. When administering a subcutaneous injection, it is advisable to avoid areas with nerves and to change the injection site with repeated doses. If severe pain occurs during injection or blood regurgitates, the needle should be removed immediately and the injection should be administered at another site; this medicine must only be used for subcutaneous injections.

Serious side effects

Shock

Mild side effects

• Chills
• nausea
• fever
• erythema
• rash
• injection site pain
• injection site redness
• breast pain
• gynecomastia

This medicine should be stored in a sealed container that blocks light and kept at a temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the effectiveness and safety of the medication.

Appearance

A brown ampoule injection containing a transparent liquid of pale yellow color

Package unit

1 ampoule (2 milliliters) × 50 ampoules